Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carsten Boess


  • Director at Health Sciences Acquisitions Corp 2 (HSAQ), 2020-08-10
  • at Rocket Pharmaceuticals Inc. (RCKT), 2020-06-19
  • Director at Avidity Biosciences Inc. (RNA), 2020-06-12
  • Large Shareholder at Kiniksa Pharmaceuticals Ltd. (KNSA), 2018-05-29
  • Svp, Chief Financial Officer at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Vice President, International at Insulet Corp (PODD), 2011-04-27
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GEVA $101.69 1,842 0 2015-02-17 Filing
GEVA $100.74 16,716 1,842 2015-02-17 Filing
GEVA $99.97 14,750 18,558 2015-02-17 Filing
GEVA $98.85 8,989 33,308 2015-02-17 Filing
GEVA $80.11 22,904 0 2014-10-30 Filing